Answers are grounded in this paper and cite their sources.
Position statement provides guidance on genetic testing in rare disorders, indicating the need for improved clinician expertise.
Next-generation sequencing (NGS)-based tests are being increasingly employed by clinicians for obtaining a genetic diagnosis in individuals and families with possible genetic disorders. However, there is a significant disparity in the genomic knowledge and skills of the clinicians employing these tests for care and management of families with rare genetic disorders. Through the current document, the Society for Indian Academy of Medical Genetics (SIAMG) aims to provide guidance and consideration in terms of the type of tests available, their appropriate applications, and result interpretation in order to make judicious use of these tests for rare disease diagnosis.
No takes yet. Share an insight, caveat, or question.
Shukla et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: